Reimbursement of biotherapy: Present status, future directions—Perspectives of the third-party payer

• 30 November 1992
• journal article
• Published by Elsevier in Seminars in Oncology Nursing
• Vol. 8  (4) , 13-16
• https://doi.org/10.1016/0749-2081(92)90049-9

Abstract

Keywords

• APPROPRIATE
• INSURERS
• NECESSITY PROGRAM
• BLUE SHIELD PLANS
• BIOTHERAPY
• CONDITIONS OF USE
• TREATMENT
• TEC

Funding Information

• National Cancer Institute